ABOUT US
We are purpose-driven serial-entrepreneurs democratizing medicine.
SpringTide is a network of experienced healthcare founders, operators, and investors in the healthcare space. With over $350M in collective exits across 4 startup companies, our Managing Partners are driven to provide access and support for fellow entrepreneurs who are expanding access to quality healthcare.
OUR INVESTMENT THESIS
A platform for democratizing medicine.
We believe strongly that cutting-edge automation technologies in software (e.g. machine learning) offer unparalleled opportunities to improve medicine in our lifetimes. These technologies have the capacity to unburden care providers and administrators of redundant, tedious, and high-liability work so they can spend more time caring for patients, skilling up, focusing on care strategy - in short, thoughtfully employing care in uniquely human ways.
As disciples of the late Harvard Business School professor Clayton Christensen, we support companies that are meaningfully extending access to quality healthcare. We believe that to be effective, these companies should have at least one strong technical founder, high growth potential validated by representative revenues and enthusiastic customers, and a brilliant solution to a problem that’s widely experienced, acutely felt, and poorly addressed by other solutions.
Managing Partners
SpringTide’s management has been investing and operating companies in the health-tech space for two decades. Between them they have significant scientific, engineering, software, AI, sales, regulatory, and general management experience. They share a common passion for starting and building new companies and improving healthcare.
Austin Walters
Austin is a serial entrepreneur, researcher, and sales leader in the health-tech field who is passionate about supporting fellow entrepreneurs, serving patients, and exploring new technologies.
Dan Lambert
Dan is a serial entrepreneur, software engineer, and technology leader who is a skilled and proven operator. He oversees all of SpringTide’s software diligence.
Yiannis Monovoukas PhD
Yiannis is a serial entrepreneur and globally respected leader in the life sciences regenerative medicine fields.
Harris Rose MD
Harris is an established orthopedic surgeon with a degree from Harvard Medical School. Prior to becoming a physician, Harris was a mechanical engineer and US Navy Submarine Officer, and is now earning his MBA from Wharton.
VENTURE PARTNERS
SpringTide Venture Partners are experienced entrepreneurs or skilled physicians who vitally contribute to the quality of our deal flow and due diligence.
ADVISORY BOARD
Our advisors include former CEOs and CIOs of Fortune 500 companies, PhDs in Engineering, and successful attorneys. They make essential contributions to our governance and strategy, investor diligence, and deal structuring.
SpringTide’s management has been investing and operating companies in the health-tech space for two decades. Between them they have significant scientific, engineering, software, AI, sales, regulatory, and general management experience. They share a common passion for starting and building new companies and improving healthcare.
Austin Walters
Austin is a serial entrepreneur, researcher, and sales leader in the health-tech field who is passionate about supporting fellow entrepreneurs, serving patients, and exploring new technologies.
Dan Lambert
Dan is a serial entrepreneur, software engineer, and technology leader who is a skilled and proven operator. He oversees all of SpringTide’s software diligence.
Yiannis Monovoukas PhD
Yiannis is a serial entrepreneur and globally respected leader in the life sciences regenerative medicine fields.
Harris Rose MD
Harris is an established orthopedic surgeon with a degree from Harvard Medical School. Prior to becoming a physician, Harris was a mechanical engineer and US Navy Submarine Officer, and is now earning his MBA from Wharton.
Our advisors include former CEOs and CIOs of Fortune 500 companies, PhDs in Engineering, and successful attorneys. They make essential contributions to our governance and strategy, investor diligence, and deal structuring.